The Jacobs Neurological Institute

The Jacobs Neurological Institute is made up of a preeminent team of neurologists and other health care professionals who provide comprehensive care for patients with neurological disorders. The JNI integrates innovative, compassionate patient care with interdisciplinary neurological research.

The Jacobs Neurological Institute is synonymous with the Department of Neurology at SUNY Buffalo and through the School of Medicine & Biomedical Sciences, it trains more than 100 medical students, neurology residents, and neurology fellows each year. The JNI conducts activities at five local hospitals, both campuses of the University at Buffalo, and two outpatient centers in Buffalo. More than 25,000 patients from all over the world are treated at the JNI each year.

Read NEWS and EVENTS at our Blog: http://ubnjacobsneuro.wordpress.com/

Message from the Chairman

Welcome to the website for the Department of Neurology, University at Buffalo School of Medicine and Biomedical Sciences (SMBS), the State University of New York (SUNY). Part of our clinical activity is contained in the Jacobs Neurological Institute, named in 2000 for Genevieve and Louis Jacobs, parents of the late Dr. Lawrence D. Jacobs, a prior chairman of the department who was instrumental in the landmark introduction of interferon beta 1A therapy in the management of multiple sclerosis.

The mission of the Univ. at Buffalo SMBS is: "To advance health and wellness across the life span for the people of New York and the world through the education of tomorrow’s leaders in health care and biomedical sciences, innovative research, and outstanding clinical care." In keeping with the institutional mission, the Department of Neurology strives to:

            1. Improve neurologic care for the people and communities of Western New York and             beyond;

            2. Educate the next generation of neurology health care providers through our             medical student clerkship and adult and child neurology residency and fellowship             training programs;

            3. Conduct high-impact, nationally and internationally-recognized research and             clinical investigation.

This is an exciting time for Buffalo, the School of Medicine, and the Department of Neurology. The state government is directing significant resources to Western New York in an effort to boost the regional economic base, including a recent pledge of $1 billion of economic incentives to Buffalo. Already the largest and most comprehensive campus in the SUNY system, the University at Buffalo is poised for even further expansion as part of UB 2020, a strategic plan that includes relocating educational, research and administrative components of the medical school to the downtown Buffalo Niagara Medical Campus. Existing clinical care facilities are being renovated on the downtown campus, including new neurologic intensive care and routine care units at Buffalo General Medical Center. The new Gates Vascular Institute that houses New York’s largest stroke and interventional neurovascular programs opened early in 2012. This building also contains a four-floor Clinical and Translational Research Center and the Jacobs Institute, designed to bring translational/clinical investigators and providers together to push forward the development of ground-breaking therapies. Outpatient clinic space for the department is also expanding. Between 2016-17, a new Children’s Hospital of Buffalo and medical office building will be arriving on the campus. In parallel with this growth, the Department of Neurology is expanding its clinical and translational faculty to build upon the adult and child neurology programs already in place.

Shortly after my relocation to Buffalo in January 2012, I placed a large bulletin board in a hallway for the faculty to post their recent full-length manuscripts, instructing them to include papers published only since 2010. Within days it was full and then more. Posted were 18 papers from the multiple sclerosis/neuroimaging group, 10 from movement disorders, 8 from neuromuscular, 7 from child neurology, 4 from epilepsy, 3 from stroke, 2 from neuro-opthalmology. And this reflects only some of the investigational activity in the department. Over the next few years I anticipate significant growth of the department in such areas as multiple sclerosis, memory disorders, epilepsy, child neurology and neuromuscular disease. And linked to this growth is the department’s commitment to contribute to the evolution of neurotherapeutics to improve the life of the many individuals in Western New York and around the world who are impacted by neurologic illness. I hope you enjoy your visit to our website.

Gil I. Wolfe, MD, FAAN
Professor and Chairman
Irvin and Rosemary Smith Chair in Neurology

 

Dr. Gil I. Wolfe, MD
Gil I. Wolfe, MD FAAN
Irvin and Rosemary Smith Professor and Chairman Univ. at Buffalo/SUNY Dept. of Neurology
     Dr. Lawrence Jacobs
     Dr. Lawrence Jacobs